Q4 2022 Holdings
Filed 2023-02-10 | 172 holdings | $2.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Unitedhealth Group Inc.(UNH) | Common | 91324P102 | $143.4M | 270,546 | 5.4% |
| Amgen Inc.(AMGN) | Common | 031162100 | $133.6M | 508,676 | 5.0% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $129.7M | 1,510,440 | 4.9% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $113.0M | 639,679 | 4.3% |
| Eli Lilly and Company(LLY) | Common | 532457108 | $105.7M | 288,917 | 4.0% |
| Vertex Pharmaceuticals Inc.(VRTX) | Common | 92532F100 | $95.4M | 330,343 | 3.6% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $87.2M | 120,862 | 3.3% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $77.3M | 478,342 | 2.9% |
| Abbott Laboratories(ABT) | Common | 002824100 | $76.1M | 693,051 | 2.9% |
| Pfizer Inc.(PFE) | Common | 717081103 | $74.7M | 1,457,170 | 2.8% |
| AstraZeneca PLC(AZN) | Sponsored ADR | 046353108 | $69.3M | 1,022,255 | 2.6% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $64.7M | 319,958 | 2.4% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $61.3M | 552,122 | 2.3% |
| Cigna Corp.(CI) | Common | 125523100 | $60.5M | 182,631 | 2.3% |
| Biogen Inc.(BIIB) | Common | 09062X103 | $54.1M | 195,430 | 2.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $51.6M | 93,705 | 1.9% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $49.5M | 687,529 | 1.9% |
| Moderna, Inc.(MRNA) | Common | 60770K107 | $47.6M | 264,927 | 1.8% |
| Horizon Therapeutics plc | Common | G46188101 | $47.2M | 415,053 | 1.8% |
| Stryker Corp.(SYK) | Common | 863667101 | $40.1M | 164,128 | 1.5% |
| Humana Inc.(HUM) | Common | 444859102 | $39.8M | 77,713 | 1.5% |
| Boston Scientific Corp.(BSX) | Common | 101137107 | $35.0M | 757,015 | 1.3% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $34.0M | 143,214 | 1.3% |
| Zimmer Biomet Holdings, Inc.(ZBH) | Common | 98956P102 | $33.0M | 258,868 | 1.2% |
| United Therapeutics Corp.(UTHR) | Common | 91307C102 | $32.0M | 115,077 | 1.2% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $31.8M | 84,021 | 1.2% |
| Intuitive Surgical, Inc.(ISRG) | Common | 46120E602 | $29.9M | 112,680 | 1.1% |
| Jazz Pharmaceuticals plc(JAZZ) | Shares | G50871105 | $29.1M | 182,782 | 1.1% |
| Danaher Corp.(DHR) | Common | 235851102 | $28.1M | 105,690 | 1.1% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $27.8M | 68,065 | 1.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $25.4M | 326,172 | 1.0% |
| HCA Healthcare, Inc.(HCA) | Common | 40412C101 | $25.2M | 105,003 | 1.0% |
| McKesson Corp.(MCK) | Common | 58155Q103 | $24.9M | 66,455 | 0.9% |
| Dexcom, Inc.(DXCM) | Common | 252131107 | $24.7M | 218,015 | 0.9% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $24.3M | 73,615 | 0.9% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $23.9M | 230,790 | 0.9% |
| Zoetis Inc.(ZTS) | Class A | 98978V103 | $20.1M | 136,914 | 0.8% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $18.3M | 140,959 | 0.7% |
| Novo Nordisk A/S(NVO) | Sponsored ADR | 670100205 | $17.7M | 130,523 | 0.7% |
| Lantheus Holdings, Inc.(LNTH) | Common | 516544103 | $17.5M | 342,872 | 0.7% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $15.8M | 72,675 | 0.6% |
| BioNTech SE(BNTX) | Sponsored ADS | 09075V102 | $15.6M | 103,858 | 0.6% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $15.1M | 123,791 | 0.6% |
| uniQure N.V.(QURE) | Shares | N90064101 | $14.8M | 652,446 | 0.6% |
| Seagen Inc.(SGENUSD) | Common | 81181C104 | $14.4M | 112,214 | 0.5% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $13.5M | 112,908 | 0.5% |
| Iqvia Holdings Inc.(IQV) | Common | 46266C105 | $12.9M | 63,117 | 0.5% |
| Guardant Health, Inc.(GH) | Common | 40131M109 | $12.8M | 472,184 | 0.5% |
| Edwards Lifesciences Corp.(EW) | Common | 28176E108 | $12.8M | 171,388 | 0.5% |
| ResMed Inc.(RMD) | Common | 761152107 | $12.6M | 60,699 | 0.5% |